United Therapeutics Corporation has signed an agreement with the Massachusetts Institute of Technology (MIT) to exclusively license breakthrough research that may lead to new ways to diagnose and treat cancer, KurzweilAI.net has learned.
A research program, funded by United Therapeutics and led by MIT Professor William Thilly and MIT Research Scientist Dr. Elena V. Gostjeva, will further explore “metakaryotic” cells that may play a role in the development of… read more
